NCT03713593 · Interventional trial
Safety and Efficacy of Lenvatinib (E7080/MK-7902) in Combination With Pembrolizumab (MK-3475) Versus Lenvatinib as First-line Therapy in Participants With Advanced Hepatocellular Carcinoma (MK-7902-002/E7080-G000-311/LEAP-002)
Overall registry status Completed
Phase 3
Conditions Carcinoma, Hepatocellular
Delaware Valley sites
- Eastern Regional Medical Center, Inc. ( Site 0626) · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory